Biopharmaceutical company ZIOPHARM Oncology, Inc. (ZIOP) said Monday that the company's President, Chief Operating Officer and Director Richard Bagley is leaving the company and stepping down from the company's board of Directors.
The company also noted that Mark Thornton, Executive Vice President, Government Affairs, Health Policy and Advocacy and Chief Quality Compliance Officer, is also leaving ZIOPHARM to pursue other opportunities.
The company said that the President of Research and Development and Chief Medical Officer, Hagop Youssoufian, will assume the additional responsibility of oversight of all regulatory affairs and clinical operations. Also Caesar Belbel, Executive Vice President, Chief Legal Officer and Secretary, will shoulder the additional responsibility for corporate and business development.
The company also noted that Jason Amello, Executive Vice President and Chief Financial Officer, will continue to be responsible for finance and information technology, and Lynn Ferrucci, Senior Vice President, Human Resources, will continue to oversee human resources.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.